Agilent Technologies ROE 2010-2025 | A

Current and historical return on equity (ROE) values for Agilent Technologies (A) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Agilent Technologies ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-04-30 $1.17B $6.14B 19.46%
2025-01-31 $1.26B $6.03B 20.95%
2024-10-31 $1.29B $5.90B 21.30%
2024-07-31 $1.41B $5.90B 23.40%
2024-04-30 $1.24B $6.21B 20.87%
2024-01-31 $1.24B $6.19B 21.15%
2023-10-31 $1.24B $5.85B 21.76%
2023-07-31 $1.13B $5.56B 20.37%
2023-04-30 $1.35B $5.78B 24.80%
2023-01-31 $1.32B $5.61B 25.05%
2022-10-31 $1.25B $5.31B 24.26%
2022-07-31 $1.33B $5.09B 25.59%
2022-04-30 $1.26B $5.12B 24.51%
2022-01-31 $1.21B $5.15B 23.75%
2021-10-31 $1.21B $5.39B 24.26%
2021-07-31 $0.99B $4.95B 20.38%
2021-04-30 $0.93B $4.81B 19.01%
2021-01-31 $0.81B $4.80B 16.68%
2020-10-31 $0.72B $4.87B 14.77%
2020-07-31 $0.69B $4.98B 14.29%
2020-04-30 $0.68B $4.77B 14.30%
2020-01-31 $0.76B $4.85B 15.70%
2019-10-31 $1.07B $4.75B 21.79%
2019-07-31 $1.07B $4.75B 22.01%
2019-04-30 $1.12B $5.13B 23.15%
2019-01-31 $1.14B $5.04B 24.27%
2018-10-31 $0.32B $4.57B 6.91%
2018-07-31 $0.30B $4.57B 6.43%
2018-04-30 $0.24B $4.62B 5.10%
2018-01-31 $0.20B $4.53B 4.27%
2017-10-31 $0.68B $4.84B 15.10%
2017-07-31 $0.63B $4.61B 14.44%
2017-04-30 $0.58B $4.38B 13.48%
2017-01-31 $0.51B $4.30B 11.94%
2016-10-31 $0.46B $4.25B 11.00%
2016-07-31 $0.48B $4.35B 11.38%
2016-04-30 $0.46B $4.17B 11.23%
2016-01-31 $0.46B $4.05B 11.14%
2015-10-31 $0.40B $4.17B 9.62%
2015-07-31 $0.28B $4.11B 6.22%
2015-04-30 $0.31B $4.16B 6.47%
2015-01-31 $0.37B $4.24B 7.01%
2014-10-31 $0.50B $5.30B 9.03%
2014-07-31 $0.69B $5.64B 12.58%
2014-04-30 $0.71B $5.63B 13.48%
2014-01-31 $0.74B $5.45B 14.21%
2013-10-31 $0.72B $5.29B 13.96%
2013-07-31 $0.94B $4.79B 18.18%
2013-04-30 $1.01B $5.31B 19.56%
2013-01-31 $1.10B $5.35B 21.89%
2012-10-31 $1.15B $5.19B 23.92%
2012-07-31 $1.02B $4.87B 22.09%
2012-04-30 $1.10B $4.73B 24.89%
2012-01-31 $1.05B $4.50B 24.72%
2011-10-31 $1.01B $4.32B 25.59%
2011-07-31 $1.02B $4.20B 27.55%
2011-04-30 $0.89B $3.96B 26.67%
2011-01-31 $0.80B $3.34B 26.56%
2010-10-31 $0.68B $3.24B 24.26%
2010-07-31 $0.42B $2.81B 15.80%
2010-04-30 $0.19B $2.63B 7.54%
2010-01-31 $-0.02B $2.60B -0.64%
2009-10-31 $-0.03B $2.51B -1.24%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $32.827B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.381B 27.82
Boston Scientific (BSX) United States $149.868B 37.52
Stryker (SYK) United States $143.347B 29.97
EssilorLuxottica (ESLOY) France $128.152B 0.00
Medtronic (MDT) Ireland $110.735B 15.70
Lonza Group Ag (LZAGY) Switzerland $49.273B 0.00
Haleon (HLN) United Kingdom $46.811B 26.69
ResMed (RMD) United States $37.196B 27.94
GE HealthCare Technologies (GEHC) United States $32.638B 15.50
Terumo (TRUMY) Japan $26.398B 34.29
Koninklijke Philips (PHG) Netherlands $21.463B 15.06
Insulet (PODD) United States $21.334B 83.74
Zimmer Biomet Holdings (ZBH) United States $18.048B 11.59
Baxter (BAX) United States $15.390B 11.49
Smith & Nephew SNATS (SNN) United Kingdom $12.627B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.442B 22.42
Lantheus Holdings (LNTH) United States $5.479B 13.82
Prestige Consumer Healthcare (PBH) United States $4.123B 18.42
Perrigo (PRGO) Ireland $3.643B 9.23
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.415B 15.55
Envista Holdings (NVST) United States $3.202B 26.61
ICU Medical (ICUI) United States $3.144B 23.18
GN Store Nord (GNNDY) Denmark $2.272B 18.82
QuidelOrtho (QDEL) United States $1.896B 13.04
LeMaitre Vascular (LMAT) United States $1.848B 41.30
AtriCure (ATRC) United States $1.554B 0.00
Acuren (TIC) United States $1.324B 0.00
AdaptHealth (AHCO) United States $1.132B 11.49
Neogen (NEOG) United States $1.072B 13.72
Green Thumb Industries (GTBIF) United States $1.042B 23.43
BioLife Solutions (BLFS) United States $1.008B 0.00
Phibro Animal Health (PAHC) United States $0.968B 12.37
InMode (INMD) Israel $0.839B 8.46
Kestra Medical Technologies (KMTS) United States $0.772B 0.00
CeriBell (CBLL) United States $0.647B 0.00
Evolus (EOLS) United States $0.598B 0.00
Owens & Minor (OMI) United States $0.567B 4.71
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.525B 0.00
Valneva SE (VALN) France $0.478B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Capricor Therapeutics (CAPR) United States $0.377B 0.00
Tilray Brands (TLRY) Canada $0.362B 0.00
SNDL (SNDL) Canada $0.328B 0.00
VAREX IMAGING (VREX) United States $0.319B 11.74
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.288B 0.00
Viemed Healthcare (VMD) United States $0.262B 22.07
Cerus (CERS) United States $0.256B 0.00
ZimVie (ZIMV) United States $0.245B 11.13
Sanara MedTech (SMTI) United States $0.242B 0.00
Quanterix (QTRX) United States $0.238B 0.00
Aurora Cannabis (ACB) Canada $0.229B 68.00
Canopy Growth (CGC) Canada $0.228B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Biote (BTMD) United States $0.217B 6.09
Cresco Labs (CRLBF) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
Brainsway (BWAY) Israel $0.206B 54.55
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.180B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.19
Verano Holdings (VRNOF) United States $0.174B 0.00
Organigram Global (OGI) Canada $0.173B 0.00
Exagen (XGN) United States $0.154B 0.00
Vireo Growth (VREOF) United States $0.132B 0.00
FitLife Brands (FTLF) United States $0.125B 0.00
Jin Medical (ZJYL) China $0.095B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.088B 11.34
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
MacroGenics (MGNX) United States $0.083B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Apyx Medical (APYX) United States $0.076B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Cytosorbents (CTSO) United States $0.074B 0.00
InterCure (INCR) Israel $0.069B 0.00
ImmuCell (ICCC) United States $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Nephros (NEPH) United States $0.053B 71.43
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 12.98
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
INLIF (INLF) $0.019B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00